Search

Your search keyword '"Ko, Y-D"' showing total 182 results

Search Constraints

Start Over You searched for: Author "Ko, Y-D" Remove constraint Author: "Ko, Y-D"
182 results on '"Ko, Y-D"'

Search Results

3. Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer

4. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

5. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

6. Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

8. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

9. Rare germline copy number variants (CNVs) and breast cancer risk

10. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

11. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

12. Rare germline copy number variants (CNVs) and breast cancer risk

13. Updated interim analysis of the GMMG-CONCEPT trial investigating Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in front-line treatment of high-risk Multiple Myeloma

14. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

15. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

16. Breast cancer risk genes - Association analysis in more than 113,000 women.

17. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

18. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

19. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

20. Gene-environment interactions relevant to estrogen and risk of breast cancer: Can gene-environment interactions be detected only among candidate snps from genome-wide association studies?.

21. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

22. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

23. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

24. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

25. Gene-environment interactions relevant to estrogen and risk of breast cancer:can gene-environment interactions be detected only among candidate SNPs from genome-wide association studies?

26. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

30. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

31. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

32. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

33. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

34. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

35. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

36. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

37. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

38. Mobilization of autologous stem cells under induction therapy with Isatuximab, Carfilzomib, Lenalidomide, Dexamethasone (Isa-KRd) in high risk myeloma patients: First results of the GMMG-CONCEPT trial

39. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

40. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

42. Genome-wide association study of germline variants and breast cancer-specific mortality

43. Genome-wide association study of germline variants and breast cancer-specific mortality

45. Genome-wide association study of germline variants and breast cancer-specific mortality.

46. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

47. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

48. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

49. Genome-wide association study of germline variants and breast cancer-specific mortality

50. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Catalog

Books, media, physical & digital resources